The Strategic Translator—that’s how healthcare business clients refer to Rebecca Gwilt’s role in their businesses.
Her ability to understand how existing and forthcoming laws and regulations impact business growth is unmatched, as is her savvy advice to help innovators thrive within a complex regulatory environment. In addition, VC firms and healthcare accelerators across the country seek her expertise in helping them understand emerging opportunities and risks long before they make headlines or influence the market.
As the cofounder of Nixon Gwilt Law, a nationally-recognized law firm exclusively serving digital health, provider, and life sciences businesses—and the investors who fund them—Rebecca thinks like the innovators she serves. She and cofounder Carrie Nixon built a responsive, technology-driven firm valuing client outcomes over billable hours. This modern take on service helps Rebecca and her team anticipate and integrate with their clients, as opposed to simply reacting to challenges after they arise.
After graduating from the top-ranked HealthCare Law program at the University of Maryland Francis King Carey School of Law, Rebecca served at the Centers for Medicare and Medicaid Services (CMS), where she worked with executive agency leadership and the President’s domestic policy counsel to develop Affordable Care Act (ACA) policy, guidance, regulations and technology contracts. She went on to become the National Healthcare Policy Director at a global information technology consulting firm.
In both roles, Rebecca was *the* translator between regulators and the healthcare innovators navigating the country’s complex legal and reimbursement landscape. This experience tapped into her natural talent as a communicator and strategist, and it laid the foundation for the transformative work she does today.
As a female founder, she's especially passionate about working with BIPOC and female entrepreneurs and founders. A federal government veteran, investor in underestimated founders, karaoke samurai, and kindness enthusiast, Rebecca lives in the traditional territory of the Powhatan Nation, colonially referred to as Richmond, VA, with her husband and three sons.
“Post-acute facilities should consider creative arrangements that align incentives with vendors—things like value-based payments and shared savings are not just for ACOs anymore. The new federal AKS safe harbors allow for much more creative pricing among providers and technology vendors,” Gwilt notes.
“There are a lot of exciting innovations out there, but ultimately you should be thinking about tech as an investment that pays dividends, financial or otherwise,” says Gwilt.
"Al tools can range broadly in price. If this technology can keep your patients from being readmitted to the hospital, then there are real financial gains to be had. However, if that’s not your pain point, a technology to help reduce readmissions might not be of value. Maybe what you’re really worried about is fall risk. There are app-based solutions that use AI to predict fall risk to help you direct your attention to the most at-risk patients. Your money might be better spent there,” she explains. “I encourage my clients not to fall into the “bright, shiny object” trap.”